Patently-O highlights Sarah A. Kagan’s recent IP Alert on the Federal Circuit arguments in Gilead Sciences v. Merck in its article, “An Interesting Pending Appeal Involving Violation of an NDA
Which Patent Trial and Appeal Board Trial Decisions Cannot be Appealed? By Sarah A. Kagan The U.S. Court of Appeals for the Federal Circuit heard oral arguments on March 6,
Inherency and Obviousness: Strange Bedfellows By Sarah A. Kagan The concept of disclosure by inherency exists in tension with the concept of obviousness. Inherency looks back at prior art
Banner & Witcoff is recognized for patent prosecution and litigation in Illinois, and prosecution in Washington, D.C. in the 2018 edition of the IAM Patent 1000. Joseph J. Berghammer is recognized for
When is a Published Patent Application Entitled to an Earlier Date as a Reference? By Sarah A. Kagan A recent petition to the U.S. Court of Appeals for the Federal
Confidentiality Agreements Get Teeth By Sarah A. Kagan Do you consider Non-Disclosure Agreements (NDAs) and Material Transfer Agreements (MTAs) mere hoops to jump through before you can get what
Jeffrey Chang encourages law students’ involvement in non-traditional pro bono opportunities in the American Bar Association’s Before the Bar blog. Click here to read the article.
Heather R. Smith-Carra examines the U.S. Court of Appeals for the Fourth Circuit’s recent decision involving the Digital Millennium Copyright Act safe harbor defense in the IPWatchdog article, “No DMCA safe harbor
Capturing Inventions from FDA Label Changes By Sarah A. Kagan The U.S. Court of Appeals for the Federal Circuit on January 9, 2018, heard oral arguments in Praxair Distribution,
Managing Intellectual Property magazine recently published an article that highlights Banner & Witcoff’s position as a top firm at the U.S. Patent and Trademark Office Patent Trial and Appeal Board in 2017.
